Furthermore, several critical details that also likely contributed to the observed between-study heterogeneity were not reported in some studies, including follow-up duration, ILD diagnostic criteria, KL-6 detection kits, and cut-off value determination methods. This evidence concerns the gene MUC1 and interstitial lung disease.